Cargando…
Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) has emerged as a major cause of cancer-related death and is the most common type of liver cancer. Due to the current paucity of drugs for HCC therapy there is a pressing need to develop new therapeutic concepts. In recent years, the role of Serum Response Factor (SRF)...
Autores principales: | Mittermeier, Constanze, Konopa, Andreas, Muehlich, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761055/ https://www.ncbi.nlm.nih.gov/pubmed/33255630 http://dx.doi.org/10.3390/cells9122540 |
Ejemplares similares
-
Pro-senescence therapy for hepatocellular carcinoma
por: Muehlich, Susanne, et al.
Publicado: (2013) -
Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
por: Cai, Xiurong, et al.
Publicado: (2022) -
Detection of Cellular Senescence in Human Primary Melanocytes and Malignant Melanoma Cells In Vitro
por: Zimmermann, Tom, et al.
Publicado: (2022) -
Molecular Mechanisms to Target Cellular Senescence in Aging and Disease
por: Marcozzi, Serena, et al.
Publicado: (2022) -
Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs
por: Kudlova, Natalie, et al.
Publicado: (2022)